Contamination Concerns Prompt EMA to Recommend Vistide Recall


The European Medicines Agency (EMU) last month asked for the recall of several products manufactured by Ben Venue Laboratories over particle contamination concerns. At the time, Gilead’s antiviral medication Vistide (cidofovir) was not included on the list of products recommended for recall, as the drug was undergoing sterilization in an effort to lower the risk [...]